Attachment J-9 Sample Client Letter.pdf
PDF 262 KB Posted
- Solicitation number
- 75F40126R00051
About this file
This is a sample client letter used by a contractor responding to a federal solicitation to request client participation in the past performance evaluation process.
The letter pertains to Solicitation Number 75F40126R00051 for Facility Operations and Maintenance Services at the Food and Drug Administration's Jefferson Laboratories Complex, National Center for Toxicological Research (NCTR) in Jefferson, Arkansas. The FDA has designated past performance as a key source selection factor and requires that clients of responding entities be identified and participate in the evaluation process. The contractor is requesting that the client complete and submit a Present and Past Performance Evaluation Questionnaire directly to the FDA via email to Warren Dutter at warren.dutter@fda.hhs.gov no later than 1:00 PM Central Time on July 15, 2026. Clients with questions regarding the questionnaire may contact Warren Dutter, FDA Contract Specialist, at 301-796-2486 or via email. The letter serves as a template with a placeholder for the offering entity's name and signature.
View the file
Other files
Show all 34
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SAMPLE CLIENT LETTER
Dear Client, We are currently responding to Solicitation Number 75F40126R00051 for Facility Operations and Maintenance Services at the Food and Drug Administration (FDA), Jefferson Laboratories Complex, National Center for Toxicological Research (NCTR), Jefferson, Arkansas. The FDA placed emphasis on past performance as a key source selection factor and requiring that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.
Therefore, enclosed is a Present and Past Performance Evaluation Questionnaire for your completion. We are requesting that you complete the questionnaire and electronically send it directly to the Food and Drug Administration at the following email address no later than 1:00 PM Central Time on July 15, 2026:
The questionnaire shall be emailed to Warren Dutter at warren.dutter@fda.hhs.gov. Again, the questionnaire must be submitted to Mr. Dutter not later than 1:00 PM Central Time on July 15, 2026.
If you have questions regarding the attached questionnaire, or require assistance, please contact Warren Dutter, FDA Contract Specialist at 301-796-2486 or warren.dutter@fda.hhs.gov.
We thank you for your prompt response in this matter.
Sincerely, {Offering Entity} mailto:warren.dutter@fda.hhs.gov mailto:warren.dutter@fda.hhs.gov mailto:warren.dutter@fda.hhs.gov mailto:warren.dutter@fda.hhs.gov
| SAMPLE CLIENT LETTER |
| SAMPLE CLIENT LETTER |
File details come from the government source that posted it. Updated .